GoodwinFK.Psychiatric side effects of levodopa in man. JAMA1977; 27: 1915–20.
2.
KeenanRE.The Eaton collaborative study of levodopa therapy in Parkinsonism. Neurology1970; 20: 46–59.
3.
LangrallHMJosephC.Evaluation of safety and efficacy of levodopa in Parkinson's disease and syndrome. Neurology1972; 22 (2): 3–16.
4.
JenkinsACSchwiegerAC.Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of Parkinsonism. Med J Aust1971; 2: 693–700.
5.
EverettGMBorcherdingJW.L-dopa: effect of concentrations of dopamine, norepinephrine, and serotonin in brains of mice. Science1970; 168: 849–50.
6.
BartholiniGPletscherA.Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase. J Pharm Pharmacol1968: 20: 228–39.
7.
BirkmayerWNeumayerE.Die moderne medikamentöse Behandlung des Parkinsonismus. Neurology1972; 202: 257–80.
8.
BirkmayerWDanielczykWNeumayerERiedererP.The balance of biogenic amines as condition for normal behavior. J Neurol Transmission1972; 33: 163–78.
9.
MillerEMNieburgHA.L-tryptophan in the treatment of levodopa-induced psychiatric disorders. Dis Nerv Sys1974; 35: 20–3.
10.
EganGPHammadGEM.Sexual disinhibition with L-tryptophan. Br Med J1976; 2: 701.
11.
HullinRPJerramT.Sexual disinhibition with L-tryptophan. Br Med J1976; 2: 1010.
